RankingsPricing
  1. US-listed companies
  2. DEXCOM INC
  3. Financials
  4. Stock-based compensation

DEXCOM INCDXCM

Market cap
$25.8B
P/E ratio
SummaryFinancials
Period EndStock-based compensation (Million USD)YoY (%)
Dec 31, 2024170+13.00%
Dec 31, 2023151+19.21%
Dec 31, 2022127+11.55%
Dec 31, 2021113-5.03%
Dec 31, 2020119+16.26%
Dec 31, 2019103+0.79%
Dec 31, 2018102-4.05%
Dec 31, 2017106-4.15%
Dec 31, 2016111+33.98%
Dec 31, 201583+65.40%
Dec 31, 201450+103.25%
Dec 31, 201325+33.70%
Dec 31, 201218+36.17%
Dec 31, 201114

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)